Acoustic Neuroma Clinical Trials
Here are the 2 most popular medical studies for acoustic neuroma
Proton Beam Therapy
Proton Radiation Therapy for Acoustic Neuroma
This trial is testing a new type of radiation called proton radiation to see if it can better target small tumors while sparing normal surrounding tissues. They will deliver the proton radiation using fractionated stereotactic radiotherapy (FSRT) and will monitor long-term hearing preservation and tumor growth.
Popular filter options for acoustic neuroma trials
Acoustic Neuroma Clinical Trials With No Placebo
View 9 acoustic neuroma medical studies that do not have a placebo group.
Behavioral Intervention
VOR Precision Training for Vestibular Disorders
This trial will explore how well the vestibular system works in normal people and in those with damage to the peripheral vestibular system, as well as how the brain can learn to improve signal recognition and precision in noisy environments.
Tyrosine Kinase Inhibitor
Crizotinib for Acoustic Neuroma
This trial will test a new drug, crizotinib, on people with Neurofibromatosis Type 2 who have a progressive vestibular schwannoma. The drug will be taken orally, continuously, for 28 days at a time, for up to 12 cycles.
Prosthesis
Cochlear Implant for Unilateral Hearing Loss Post-Surgery
This trial is testing whether it is safe and effective to use a cochlear implant on people who are losing their hearing in one ear due to surgery. The implant is a devices that helps people with hearing loss hear. It is approved for use in people with hearing loss in both ears, but this study will test whether it is effective for people with hearing loss in just one ear.
Frequently Asked Questions
Introduction to acoustic neuroma
What are the top hospitals conducting acoustic neuroma research?
In the realm of acoustic neuroma clinical trials, the University of California Los Angeles (UCLA) takes center stage. Though comparatively smaller in scale with just one active trial and a sole recorded study to date, UCLA's commitment to advancing knowledge about this unique condition is no less significant. Acoustic neuromas are benign tumors that develop on the nerve responsible for hearing and balance within the inner ear. These rare growths can lead to symptoms such as hearing loss, tinnitus (ringing in the ears), dizziness, and facial numbness. Located in vibrant Los Angeles, UCLA's pioneering efforts in researching acoustic neuroma since 2015 demonstrate their dedication to unraveling its complexities and finding innovative solutions.
Acoustic neuromas present a unique challenge due to their location near critical nerves involved in hearing and balance. Despite being noncancerous, these tumors can still cause significant disruptions to daily life for those affected by them. By conducting clinical trials at UCLA and collecting valuable data on new treatments or interventions for acoustic neuromas, researchers strive not only to improve patient outcomes but also enhance our understanding of this enigmatic condition.
The University of California Los Angeles' involvement in acoustic neuroma research showcases their commitment towards pushing boundaries and exploring uncharted territories within medical science - even when faced with lesser-extensively studied conditions like this one. It serves as a reminder that groundbreaking discoveries can come from unexpected places; every step taken brings us closer towards breakthroughs that hold potential for transforming lives impacted by acoustic neuromas worldwide
Which are the best cities for acoustic neuroma clinical trials?
Los Angeles, California emerges as a prominent city for acoustic neuroma clinical trials. With one active trial underway, researchers are investigating the effectiveness of RAD001 and everolimus in treating this condition. This city serves as a hub for cutting-edge research and offers individuals with acoustic neuroma an opportunity to participate in ongoing studies that could potentially lead to improved treatment options and better outcomes.
Which are the top treatments for acoustic neuroma being explored in clinical trials?
Clinical trials continue to explore potential treatments for acoustic neuroma, with one standout contender taking the lead. RAD001, also known as everolimus, is currently being tested in one active trial specifically targeting acoustic neuroma. Since its debut in 2015, this treatment has shown promising results and offers hope for patients suffering from this condition. With ongoing research and development, RAD001 may prove to be a significant breakthrough in the fight against acoustic neuroma.
What are the most recent clinical trials for acoustic neuroma?
Exciting developments are underway in the field of acoustic neuroma research, with recent clinical trials shedding light on potential treatment options. One such trial is investigating the effectiveness of RAD001, also known as everolimus, for patients with acoustic neuroma. This Phase 2 study aims to determine if everolimus can offer therapeutic benefits for individuals affected by this condition. By exploring innovative approaches like these, researchers are paving the way towards improved management and outcomes for those living with acoustic neuroma.
What acoustic neuroma clinical trials were recently completed?
Recently completed clinical trials have made significant strides in advancing the understanding and treatment of acoustic neuroma. These include a trial for Tumor Treating Fields (TTF) therapy sponsored by Novocure, which concluded in October 2021. In August 2021, a trial investigating the use of bevacizumab was completed under the sponsorship of Massachusetts General Hospital. Furthermore, an investigational study on RAD-111, led by Curium Pharma LLC., reached completion in July 2021. These groundbreaking trials bring hope to individuals affected by acoustic neuroma and highlight ongoing efforts to improve patient outcomes through innovative research and therapies.